News · Adamas Trust, Inc. (ADAM) · Real Estate

Adamas Trust falls 3.5% after modest trading as firm schedules October results

Session of October 19, 2026 · Published October 20, 2026 · 3 min read

What happened

Adamas Trust (ADAM) fell 3.5% on October 19, 2026, after the company scheduled an October 28 results release that coincided with the session. The stock closed at $7.37 after opening 0.3% below the previous close, and trading volume was 0.7 times its 20-day average. The move occurred while the S&P 500 rose 0.4% and the Real Estate sector median fell 1.7%.

$8.00$9.00Sep 8Sep 17Sep 28Oct 8Oct 19ADAM closing price, last 30 sessionspromtfinance.com$7.37 (-3.5%)
Closing price over the last 30 trading sessions. On October 19, 2026, ADAM closed at $7.37, down 3.5% on the day and 24.1% lower than 30 sessions earlier.

How big was the move

The decline was 2.0 times a typical daily move for this stock, a large session driven partly by market and sector trends and partly by company-specific news. The stock’s market sensitivity is modest: it has a beta of 0.83, so it historically moves less than the market. Over the last five sessions the stock fell 3.9% while the S&P 500 over five sessions fell 1.5%, and the session’s result was 1.9 percentage points worse than the sector median.

-5%0%+5%Jul 27Aug 24Sep 21Oct 19ADAM daily moves, last 60 sessions2 std. dev. bandpromtfinance.com
Each bar is one day's price change; the outlined bar is October 19, 2026. A typical daily move over the past year was 2.0%, so the latest move equals 1.7 times that. Moves outside the dashed lines (about 4.1%) are unusual.

In the past five years the stock had 56 sessions with a decline of at least 3.5%; twenty trading days later the median result was a gain of 5.1%, with 38 of 56 higher. That historical pattern is context, not a forecast, and the link between the October 19 move and the scheduled results should be drawn cautiously.

The technical picture

The stock sat 5.9% below its 20-day moving average, 17.4% below its 50-day moving average and 13.8% below its 200-day moving average. The 50-day average is above the 200-day average, a sign of an established uptrend despite recent weakness. The 14-day Relative Strength Index was 27, below 30, a level often called oversold, and the shares were 28.9% below the 52-week high.

$8.00$10.00Oct '25Jan '26Apr '26Jul '26Oct '26ADAM one-year price and moving averages200-day50-dayPricepromtfinance.com52-week high $10.2352-week low $6.58
Closing price over the past year. ADAM ends the period 28.0% below its 52-week high, below its 50-day average ($8.92) and below its 200-day average ($8.55).

Momentum has been weak recently: the stock fell 17.3% over one month and fell 16.7% over three months. One-year performance was up 8.7%, 7.3 percentage points behind the S&P 500. Volatility was 28% annualized over 60 days, lower than 77% of its own readings over five years.

Fundamentals and valuation

For the four quarters through June 30, 2026, Adamas Trust reported revenue of $956.7 million and diluted earnings per share of $1.68. Revenue grew 57.3% from a year earlier and earnings per share growth from a year earlier rose 425.0%. Gross margin was 57.3% versus 45.2% a year earlier, and operating margin was 38.0% versus 21.2% a year earlier.

$0.00$100M$200MQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26ADAM quarterly revenuepromtfinance.com$135M$130M$187M$157M$227M$236M$267M$228M
Quarterly revenue by period end. The latest quarter brought $228M, 45.2% more than the same quarter a year earlier.

Free-cash-flow margin was 16.3% and return on invested capital was 5.0%. The balance sheet showed net debt of 28.0 times EBITDA, and share count over one year increased by 2.2%. Valuation metrics showed the stock at 4.4 times trailing earnings, the lowest reading of the past five years versus a five-year median of 7.8 times earnings, and 5.7 times expected forward earnings. Free-cash-flow yield was 22.8%.

Earnings and analyst expectations

Adamas Trust last reported on July 29, 2026, with earnings per share of $0.47 against $0.24 expected, 96.8% above estimates. The company had beaten estimates in four consecutive quarters, with an average surprise over the last four reports of 100.0% above estimates. Typical two-day reactions after recent reports were modest, with the stock falling 0.6%.

-$0.50$0.00$0.50Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26ADAM quarterly earnings per sharepromtfinance.com$0.36-$0.46$0.33$0.09$0.36$0.45$0.40$0.47
Diluted earnings per share by quarter. The latest quarter shows $0.47, against $0.09 in the same quarter a year earlier.

The company said it would release results for the three- and nine-month periods ended September 30, 2026, after market close on October 28, 2026, and would hold a conference call and audio webcast with executive management at 9:00 a.m. on October 29, 2026, according to GlobeNewsWire. The next scheduled report is November 4, 2026.

Analysts give a consensus rating of Buy from four analysts, with half of those rating the stock Buy and a consensus price target of $9.50, 28.9% above the closing price.

What to watch

  • October 28, 2026: scheduled release of results for the three- and nine-month periods ended September 30, 2026.
  • October 29, 2026, at 9:00 a.m.: conference call and audio webcast with executive management.
  • November 4, 2026: listed next report date.
  • Valuation metrics at close: 4.4 times trailing earnings and free-cash-flow yield of 22.8%.
  • Balance sheet metric: net debt of 28.0 times EBITDA.

Related stocks

More news from PromtFinance

Related stories from the last 48 hours

NMRKReal EstateOct 19Newmark fell 4.7% after launching Industrial Outdoor Storage practiceNewmark (NMRK) fell 4.7% on October 19, 2026, after announcing an Industrial Outdoor Storage specialty practice; session volume was 1.1 times its 20-day average.Read the analysis →SBRAReal EstateOct 19Sabra Health Care REIT falls 1.3% as volume picks up and company sets Q3 reporting dateSabra Health Care REIT fell 1.3% on October 19, 2026, as volume rose and the company announced its third-quarter earnings timetable.Read the analysis →SRUtilitiesOct 19Spire falls 1.0% after ordinary session as company schedules November callSpire (SR) slipped 1.0% on October 19, 2026, in an ordinary session; the utility set a November 17 conference call to review fiscal 2026 results.Read the analysis →WRBFinancial ServicesOct 19W. R. Berkley falls after quarterly results show modest beat and record underwriting profitW. R. Berkley fell 1.8% on October 19, 2026, because of its quarterly results that showed a small EPS beat and record underwriting profit.Read the analysis →FMCBasic MaterialsOct 19FMC falls after law firm probes and scrutiny of operating challengesFMC fell 5.3% on October 19, 2026, as law firm investigations and analyst notes highlighted revenue pressure and margin concerns.Read the analysis →GRALHealthcareOct 16GRAIL falls 13.0% after disclosure of CEO share sale amid weak sessionGRAIL fell 13.0% on October 16, 2026, after disclosure of a CEO stock sale; the move was largely company-specific and came as trading outpaced the market.Read the analysis →BOKFFinancial ServicesOct 19BOK Financial falls after third-quarter earnings beat but stock retreatsBOK Financial fell 1.6% on October 19, 2026, because third-quarter results beat estimates while the stock trades below key moving averages.Read the analysis →